Evidence map›Paper›PMID 37949145›Full record

ArticleThe Science of the total environment2024

Elevated parkinsonism pathological markers in dopaminergic neurons with developmental exposure to atrazine.

Han Zhao, Junkai Xie, Shichen Wu, Xihui Zhao, Oscar F Sánchez, Sehong Min, Jean-Christophe Rochet, Jennifer L Freeman, Chongli Yuan

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in The Science of the total environment, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Environmental Risk Factors for Parkinson's Disease: A Critical Review and Policy Implications.Movement disorders : official journal of the Movement Disorder Society · 2025
    Review
  6. Advancing Environmental ToxicologyEnvironment & health (Washington, D.C.) · 2024
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Han ZhaoDavidson School of Chemical Engineering, Purdue University, West Lafayette, IN 47907, United States of America.
Junkai XieDavidson School of Chemical Engineering, Purdue University, West Lafayette, IN 47907, United States of America.
Shichen WuDavidson School of Chemical Engineering, Purdue University, West Lafayette, IN 47907, United States of America.
Xihui ZhaoWeldon School of Biomedical Engineering, Purdue University, West Lafayette, IN 47907, United States of America.
Oscar F SánchezDavidson School of Chemical Engineering, Purdue University, West Lafayette, IN 47907, United States of America.
Sehong MinDepartment of Medicinal Chemistry and Molecular Pharmacy, Purdue University, West Lafayette, IN 47907, United States of America.
Jean-Christophe RochetDepartment of Medicinal Chemistry and Molecular Pharmacy, Purdue University, West Lafayette, IN 47907, United States of America; Purdue Institute of Integrated Neuroscience, Purdue University, West Lafayette, IN 47907, United States of America.
Jennifer L FreemanSchool of Health Sciences, Purdue University, West Lafayette, IN 47907, United States of America; Purdue Institute of Integrated Neuroscience, Purdue University, West Lafayette, IN 47907, United States of America.
Chongli YuanDavidson School of Chemical Engineering, Purdue University, West Lafayette, IN 47907, United States of America; Purdue Institute of Integrated Neuroscience, Purdue University, West Lafayette, IN 47907, United States of America; Purdue Center of Cancer Research, West Lafayette, IN 47907, United States of America. Electronic address: cyuan@purdue.edu.
Purdue University West Lafayette · US

Funding

Modeling functional genomics of susceptibility to the persistent effects of environmental toxins in an elderly rural Indiana neurodegenerative cohortR01AG080917 · NIA · PURDUE UNIVERSITY · PI Aaron B Bowman, Chongli Yuan · 2022 to 2026
$4.1M
NIA NIH HHS R01 AG080917
6 · The paper itself

Abstract

Atrazine (ATZ) is one of the most used herbicides in the US and a known endocrine disruptor. ATZ is frequently detected in drinking water, especially in Midwestern regions of the United States, exceeding the EPA regulation of maximum contamination level (MCL) of 3 ppb. Epidemiology studies have suggested an association between ATZ exposure and neurodegeneration. Less, however, is known about the neurotoxic mechanism of ATZ, particularly for exposures at a developmental stage. Here, we exposed floor plate progenitors (FPPs) derived from human induced pluripotent stem cells (hiPSCs) to low concentrations of ATZ at 0.3 and 3 ppb for two days followed by differentiation into dopaminergic (DA) neurons in ATZ-free medium. We then examined the morphology, activity, pathological protein aggregation, and transcriptomic changes of differentiated DA neurons. We observed significant decrease in the complexity of neurite network, increase of neuronal activity, and elevated tau- and α-synuclein (aSyn) pathologies after ATZ exposure. The ATZ-induced neuronal changes observed here align with pathological characteristics in Parkinson's disease (PD). Transcriptomic analysis further corroborates our findings; and collectively provides a strong evidence base that low-concentration ATZ exposure during development can elicit increased risk of neurodegeneration.

Indexed as

AtrazineHerbicidesInduced Pluripotent Stem CellsParkinson DiseaseDopaminergic NeuronsHumansAtrazineHerbicidesAtrazine EPA regulation levelAtrazine health effectsDopaminergic neuronsParkinson's diseaseTauopathy

Identifiers

PMID37949145
PMCPMC10843769
OpenAlexW4388492061

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.